Zobrazeno 1 - 10
of 91
pro vyhledávání: '"R B Devereux"'
Publikováno v:
European Heart Journal. 43
Background Hypertension and left ventricular hypertrophy (LVH) are predictors of atrial fibrillation (AF) and heart failure (HF). The incidence rates of AF and HF and especially the combination of these two complications in hypertensive patients with
Autor:
C Bang, L Gerholt, E Gerdts, A C Larstorp, S Kjeldsen, S Julius, K Wachtell, P Okin, R B Devereux
Publikováno v:
European Heart Journal. 43
Background Recently increased left atrial systolic force (LASF), a measure of left atrial function, has been associated with left ventricular hypertrophy (LVH) in hypertensive patients. Impaired left ventricular relaxation is often seen in hypertensi
Publikováno v:
High Blood Pressure & Cardiovascular Prevention. 14:145-196
Publikováno v:
American journal of medical genetics, 62(4), 417-426. Wiley-Liss Inc.
In 1986, the diagnosis of the Marfan syndrome was codified on the basis of clinical criteria in the Berlin nosology [Beighton et al., 1988]. Over time, weaknesses have emerged in these criteria, a problem accentuated by the advent of molecular testin
Autor:
G, de Simone, R B, Devereux
Publikováno v:
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology. 3(3)
Active reduction of left ventricular chamber size during systole is the final effect of complex interaction mechanisms involving layers of differently oriented myocardial fibres, the shortening of which is less than the one measured as shortening of
Autor:
V, Palmieri, R B, Devereux
Publikováno v:
Minerva cardioangiologica. 50(3)
In arterial hypertension, left ventricular (LV) hypertrophy (H) is a prognostically relevant target organ damage associated with systolic and diastolic LV dysfunction. The level of LV dysfunction seems to be related to the degree of myocardial fibros
Autor:
M H, Olsen, K, Wachtell, K, Borch-Johnsen, P M, Okin, S E, Kjeldsen, B, Dahlöf, R B, Devereux, H, Ibsen
Publikováno v:
Journal of human hypertension. 16(8)
In the Losartan Intervention For Endpoint reduction (LIFE) study left ventricular (LV) hypertrophy was associated with increased urine albumin/creatinine ratio (UACR) at baseline. To evaluate whether this association was due only to parallel blood pr
Autor:
A, Celentano, M, Crivaro, M J, Roman, I, Pietropaolo, R, Greco, P, Pauciullo, C, Lirato, R B, Devereux, G, de Simone
Publikováno v:
Nutrition, metabolism, and cardiovascular diseases : NMCD. 11(5)
To investigate the effect of hypercholesterolemia on total arterial compliance and left ventricular (LV) geometry in the absence of arterial hypertension and diabetes.One hundred and fifty-two normotensive, non-diabetic patients (109 men) aged 52 +/-
Autor:
D K, Arnett, Y, Hong, J N, Bella, A, Oberman, D W, Kitzman, P N, Hopkins, D C, Rao, R B, Devereux
Publikováno v:
American journal of hypertension. 14(12)
Evidence suggests that left ventricular (LV) mass is under genetic control, independently of risk factors known to influence LV size and geometry.As part of the HyperGEN study, four field centers recruited African American and white hypertensive sibl
Autor:
L, Oikarinen, M S, Nieminen, M, Viitasalo, L, Toivonen, K, Wachtell, V, Papademetriou, S, Jern, B, Dahlöf, R B, Devereux, P M, Okin
Publikováno v:
Journal of hypertension. 19(10)
In hypertensive patients, left ventricular hypertrophy (LVH) predicts increased mortality, in part due to an increased incidence of sudden death. Repolarization-related arrhythmogenesis may be an important mechanism of sudden death in hypertensive pa